Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: ACBI-2, ACBI 2

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $619 | - | In Stock | |
| 10 mg | $993 | - | In Stock | |
| 25 mg | Preferential | - | In Stock |
| Description | ACBI2 is a highly potent and orally active VHL-recruiting PROTAC (EC50=7 nM) that degrades SMARCA2 (DC50=1 nM in RKO cells). ACBI2 can be used in lung cancer research. |
| Targets & IC50 | VHL:7 nM (EC50), A549:30 nM (GI50) |
| In vitro | ACBI2 degrades SMARCA2 and SMARCA4 in RKO cells, with DC50s of 1 nM and 32 nM, respectively [1]. ACBI2 (0.1 nM–1 μM, 4–18 hours) rapidly and completely degrades SMARCA2 in two sensitive cell lines (A549 and NCI-H1568) [1]. ACBI2 (1 nM–1 μM, 18 hours) significantly degrades SMARCA2 and exhibits greater selectivity than SMARCA4 [1]. ACBI2 (0–1 μM; 18 hours) degrades SMARCA2 in human whole blood in a dose-dependent manner [1]. |
| In vivo | ACBI2 (80 mg/kg, oral, once daily) significantly inhibited tumor growth in a mouse model of A549 xenografts [1]. ACBI2 (5–100 mg/kg, oral, with tumors harvested 24 or 48 hours after treatment) dose-dependently downregulated SMARCA2 (IHC staining) in A549-bearing mice [1]. The oral bioavailability of ACBI2 (30 mg/kg, oral, in mice) was 22% [1]. |
| Synonyms | ACBI-2, ACBI 2 |
| Molecular Weight | 1064.16 |
| Formula | C56H68BrFN8O5S |
| Cas No. | 2913161-19-8 |
| Smiles | O=C1N=C2N(C=3C(N2C4CCCC4)=CC(=CC3)C5CCN(CC[C@H](CC[C@H](NC(=O)[C@H]6N(C([C@@H](NC(=O)C7(F)CC7)C(C)(C)C)=O)C[C@H](O)C6)C8=CC=C(C=C8)C9=C(C)N=CS9)C)CC5)C=%10C1=C(Br)C=CC%10 |
| Storage | Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 100 mg/mL (93.97 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.